
Eli Lilly Launches Redesign Clinical Trial Info Challenge
The HIT Consultant website reports that Eli Lilly, one of the world’s largest pharmaceutical companies, invites designers and developers to re-imagine clinical trial information in a patient-centric way. As part of Lilly’s Clinical Open Innovation initiative, which calls on open innovation to help transform clinical research and development,
Comments Off on Eli Lilly Launches Redesign Clinical Trial Info Challenge • Read this story »